Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study

Published:2024-08 Issue: Volume:74 Page:102700
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

He Min,Hao Shuang,Ma LinXiaoxi,Xiu BingQiu^ORCID,Yang BenLong,Wang ZeHao^ORCID,Xue JingYan,Chi YaYun,Xiong Min,Chen JiaJian,Huang XiaoYan,Liu XiYu,Wu SongYang,Xiao Qin,Huang Yan,Shui RuoHong,Cao AYong,Li JunJie,Di GenHong,Yang WenTao,Hu Xin,Liu GuangYu,Yu KeDa,Jiang YiZhou,Wang ZhongHua,Shao ZhiMing,Wu Jiong^ORCID

Publisher

Elsevier BV

Reference29 articles.

1. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat Rev Clin Oncol,2016

2. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States;Mougalian;Cancer,2015

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

4. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion 130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial;Schmid;Lancet Oncol,2020

5. Pembrolizumab for early triple-negative;Schmid;Breast Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP